标题
CDK5 in oncology: recent advances and future prospects
作者
关键词
-
出版物
Future Medicinal Chemistry
Volume 9, Issue 16, Pages 1939-1962
出版商
Future Science, LTD
发表日期
2017-10-27
DOI
10.4155/fmc-2017-0097
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cdk5 links with DNA damage response and cancer
- (2017) Wan Liu et al. Molecular Cancer
- Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies
- (2017) David J. Byun et al. Nature Reviews Endocrinology
- Pro-survival signal inhibition by CDK inhibitor dinaciclib in Chronic Lymphocytic Leukaemia
- (2016) Yixiang Chen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Anti-angiogenic effects of novel cyclin-dependent kinase inhibitors with a pyrazolo[4,3-d]pyrimidine scaffold
- (2016) S Zhang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cdk5 Directly Targets Nuclear p21 CIP1 and Promotes Cancer Cell Growth
- (2016) Pao-Hsuan Huang et al. CANCER RESEARCH
- Targeting CDK9: a promising therapeutic opportunity in prostate cancer
- (2016) Muhammed H Rahaman et al. ENDOCRINE-RELATED CANCER
- 5-Substituted 3-isopropyl-7-[4-(2-pyridyl)benzyl]amino-1(2)H-pyrazolo[4,3-d]pyrimidines with anti-proliferative activity as potent and selective inhibitors of cyclin-dependent kinases
- (2016) Ladislava Vymětalová et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- TFP5/TP5 peptide provides neuroprotection in the MPTP model of Parkinson′s disease
- (2016) HarishC Pant et al. Neural Regeneration Research
- STMC-24. NOVEL INHIBITOR OF CDK5 SIGNALING AXIS SUPPRESSES SELF-RENEWAL PROPERTIES OF GBM STEM CELLS AND INDUCES APOPTOSIS
- (2016) Subhas Mukherjee et al. NEURO-ONCOLOGY
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
- (2016) Gabriel N. Hortobagyi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity
- (2016) R. D. Dorand et al. SCIENCE
- Inflammation helps tumors evade immune detection
- (2016) L. K. Ferrarelli Science Signaling
- A unique type of GSK-3 inhibitor brings new opportunities to the clinic
- (2016) A. Licht-Murava et al. Science Signaling
- CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5–AP-1 axis
- (2016) Kangmin Zhuang et al. Cell Death & Disease
- Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis
- (2016) Henriette Merk et al. Oncotarget
- Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma
- (2016) Julia Herzog et al. Oncotarget
- Inflammation helps tumors evade immune detection
- (2016) L. K. Ferrarelli Science Signaling
- A unique type of GSK-3 inhibitor brings new opportunities to the clinic
- (2016) A. Licht-Murava et al. Science Signaling
- Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis
- (2016) Ya-Li Zheng et al. PLoS One
- Cyclin I and p35 determine the subcellular distribution of Cdk5
- (2015) Henning Hagmann et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Targeting CDK6 in cancer: State of the art and new insights
- (2015) Solomon Tadesse et al. CELL CYCLE
- Cdk5 promotes DNA replication stress checkpoint activation through RPA-32 phosphorylation, and impacts on metastasis free survival in breast cancer patients
- (2015) Sara Chiker et al. CELL CYCLE
- Tamoxifen Inhibits CDK5 Kinase Activity by Interacting with p35/p25 and Modulates the Pattern of Tau Phosphorylation
- (2015) Caroline Corbel et al. CHEMISTRY & BIOLOGY
- Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 – 2014)
- (2015) Veronika Malínková et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination
- (2015) Toshiyuki Takasugi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Heat Shock Inhibition of CDK5 Increases NOXA Levels through miR-23a Repression
- (2015) Trevor M. Morey et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery and development of Seliciclib. How systems biology approaches can lead to better drug performance
- (2015) Hilal S. Khalil et al. JOURNAL OF BIOTECHNOLOGY
- Targeting cyclin dependent kinase 5 in hepatocellular carcinoma – A novel therapeutic approach
- (2015) Sandra M. Ehrlich et al. JOURNAL OF HEPATOLOGY
- Cdk5 Regulates Activity-Dependent Gene Expression and Dendrite Development
- (2015) Z. Liang et al. JOURNAL OF NEUROSCIENCE
- Cyclin-dependent kinase 5 acts as a critical determinant of AKT-dependent proliferation and regulates differential gene expression by the androgen receptor in prostate cancer cells
- (2015) Julia Lindqvist et al. MOLECULAR BIOLOGY OF THE CELL
- Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma
- (2015) Shan-Shan Sun et al. Molecular Cancer
- Cyclin-dependent kinase 5 regulates the proliferation, motility and invasiveness of lung cancer cells through its effects on cytoskeletal remodeling
- (2015) JUN-LI LIU et al. Molecular Medicine Reports
- The Role of Cdk5 in Alzheimer’s Disease
- (2015) Shu-Lei Liu et al. MOLECULAR NEUROBIOLOGY
- Mitochondrial control by DRP1 in brain tumor initiating cells
- (2015) Qi Xie et al. NATURE NEUROSCIENCE
- The history and future of targeting cyclin-dependent kinases in cancer therapy
- (2015) Uzma Asghar et al. NATURE REVIEWS DRUG DISCOVERY
- CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis
- (2015) Shu Zhang et al. PLoS One
- The early synthesis of p35 and activation of CDK5 in LPS-stimulated macrophages suppresses interleukin-10 production
- (2015) Yi Rang Na et al. Science Signaling
- Cyclin-Dependent Kinase 5 (CDK5) Controls Melanoma Cell Motility, Invasiveness, and Metastatic Spread—Identification of a Promising Novel therapeutic target
- (2015) Savita Bisht et al. Translational Oncology
- Targeting Breast Cancer with CDK Inhibitors
- (2015) Erica L. Mayer Current Oncology Reports
- Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis
- (2015) Karine Pozo et al. Oncotarget
- The early synthesis of p35 and activation of CDK5 in LPS-stimulated macrophages suppresses interleukin-10 production
- (2015) Yi Rang Na et al. Science Signaling
- Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors
- (2015) Marion Peyressatre et al. Cancers
- An Inhibitor’s-Eye View of the ATP-Binding Site of CDKs in Different Regulatory States
- (2014) Aude Echalier et al. ACS Chemical Biology
- Discovery of thienoquinolone derivatives as selective and ATP non-competitive CDK5/p25 inhibitors by structure-based virtual screening
- (2014) Arindam Chatterjee et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma
- (2014) S. K. Kumar et al. BLOOD
- Phosphorylation of Cyclin-dependent Kinase 5 (Cdk5) at Tyr-15 Is Inhibited by Cdk5 Activators and Does Not Contribute to the Activation of Cdk5
- (2014) Hiroyuki Kobayashi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CDK5 is a major regulator of the tumor suppressor DLC1
- (2014) Brajendra K. Tripathi et al. JOURNAL OF CELL BIOLOGY
- Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis
- (2014) J-K Jin et al. ONCOGENE
- Exploring structural requirements of leads for improving activity and selectivity against CDK5/p25 in Alzheimer's disease: an in silico approach
- (2014) Pravin Ambure et al. RSC Advances
- Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains
- (2013) Mathew P. Martin et al. ACS Chemical Biology
- Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser727 on STAT3 in prostate cancer cells
- (2013) Fu-Ning Hsu et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The Role of Cdk5 in Neuroendocrine Thyroid Cancer
- (2013) Karine Pozo et al. CANCER CELL
- Cyclin I is involved in the regulation of cell cycle progression
- (2013) Taiki Nagano et al. CELL CYCLE
- A Novel Series of Highly Potent 2,6,9-Trisubstituted Purine Cyclin-Dependent Kinase Inhibitors
- (2013) Tomáš Gucký et al. JOURNAL OF MEDICINAL CHEMISTRY
- Specific Inhibition of p25/Cdk5 Activity by the Cdk5 Inhibitory Peptide Reduces Neurodegeneration In Vivo
- (2013) J. R. Sundaram et al. JOURNAL OF NEUROSCIENCE
- Targeting Constitutively Activated β 1 Integrins Inhibits Prostate Cancer Metastasis
- (2013) Yu-Chen Lee et al. MOLECULAR CANCER RESEARCH
- Novel Inhibitors of Cyclin-Dependent Kinases Combat Hepatocellular Carcinoma without Inducing Chemoresistance
- (2013) C. Haider et al. MOLECULAR CANCER THERAPEUTICS
- Trisubstituted Pyrazolopyrimidines as Novel Angiogenesis Inhibitors
- (2013) Sabine B. Weitensteiner et al. PLoS One
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Extraneuronal activities and regulatory mechanisms of the atypical cyclin-dependent kinase Cdk5
- (2012) Abul Arif BIOCHEMICAL PHARMACOLOGY
- Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)/p25 inhibitors
- (2012) Jonas Malmström et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Potent inhibitors of CDK5 derived from roscovitine: Synthesis, biological evaluation and molecular modelling
- (2012) Luc Demange et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Level of cdk5 expression predicts the survival of relapsed multiple myeloma patients
- (2012) Zachary Levacque et al. CELL CYCLE
- Identification of Unique MEK-Dependent Genes in GNAQ Mutant Uveal Melanoma Involved in Cell Growth, Tumor Cell Invasion, and MEK Resistance
- (2012) G. Ambrosini et al. CLINICAL CANCER RESEARCH
- Synthesis and in vitro biological evaluation of 2,6,9-trisubstituted purines targeting multiple cyclin-dependent kinases
- (2012) Marek Zatloukal et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway
- (2012) Abeba Demelash et al. MOLECULAR BIOLOGY OF THE CELL
- Disrupting the PIKE-A/Akt interaction inhibits glioblastoma cell survival, migration, invasion and colony formation
- (2012) Q Qi et al. ONCOGENE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Cyclin-Dependent Kinases in Brain Development and Disease
- (2011) Susan C. Su et al. Annual Review of Cell and Developmental Biology
- An in silico approach for the discovery of CDK5/p25 interaction inhibitors
- (2011) Bing Zhang et al. Biotechnology Journal
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Expression analysis and molecular targeting of cyclin-dependent kinases in advanced melanoma
- (2011) Christopher Abdullah et al. CELL CYCLE
- The impact of cyclin-dependent kinase 5 depletion on poly(ADP-ribose) polymerase activity and responses to radiation
- (2011) Celeste Bolin et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Twice switched at birth: Cell cycle-independent roles of the “neuron-specific” cyclin-dependent kinase 5 (Cdk5) in non-neuronal cells
- (2011) Johanna Liebl et al. CELLULAR SIGNALLING
- Cyclin-Dependent Kinase 5 Is Amplified and Overexpressed in Pancreatic Cancer and Activated by Mutant K-Ras
- (2011) J. P. Eggers et al. CLINICAL CANCER RESEARCH
- Beyond ATM: The protein kinase landscape of the DNA damage response
- (2011) Ariel Bensimon et al. FEBS LETTERS
- Regulation of Androgen Receptor and Prostate Cancer Growth by Cyclin-dependent Kinase 5
- (2011) Fu-Ning Hsu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine: Evaluation of a Novel Selective Inhibitor of Cyclin-Dependent Kinases with Antiproliferative Activity
- (2011) Radek Jorda et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
- (2011) Jang Hyun Choi et al. NATURE
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- Cdk5: Multitasking between physiological and pathological conditions
- (2011) Joao P. Lopes et al. PROGRESS IN NEUROBIOLOGY
- A Cell-Based High-Content Screening Assay Reveals Activators and Inhibitors of Cancer Cell Invasion
- (2011) M. Quintavalle et al. Science Signaling
- Cdk5: a multifaceted kinase in neurodegenerative diseases
- (2011) Zelda H. Cheung et al. TRENDS IN CELL BIOLOGY
- Inhibiting the Cyclin-Dependent Kinase CDK5 Blocks Pancreatic Cancer Formation and Progression through the Suppression of Ras-Ral Signaling
- (2010) Georg Feldmann et al. CANCER RESEARCH
- Cdk5, the multifunctional surveyor
- (2010) Vassiliki Lalioti et al. CELL CYCLE
- p35 Is Required for CDK5 Activation in Cellular Senescence
- (2010) Daqin Mao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The cdk5 Kinase Regulates the STAT3 Transcription Factor to Prevent DNA Damage upon Topoisomerase I Inhibition
- (2010) Sandy Courapied et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cyclin-dependent Kinase 5 Regulates Endothelial Cell Migration and Angiogenesis
- (2010) Johanna Liebl et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis
- (2010) Tej K. Pareek et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Regulation and role of cyclin-dependent kinase activity in neuronal survival and death
- (2010) Shin-ichi Hisanaga et al. JOURNAL OF NEUROCHEMISTRY
- Role of a cdk5-associated protein, p35, in herpes simplex virus type 1 replicationin vivo
- (2010) Steve D Haenchen et al. JOURNAL OF NEUROVIROLOGY
- Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor
- (2010) David Parry et al. MOLECULAR CANCER THERAPEUTICS
- The Proapoptotic Function of Noxa in Human Leukemia Cells Is Regulated by the Kinase Cdk5 and by Glucose
- (2010) Xazmin H. Lowman et al. MOLECULAR CELL
- Conditional Deletion of Neuronal Cyclin-Dependent Kinase 5 in Developing Forebrain Results in Microglial Activation and Neurodegeneration
- (2009) Satoru Takahashi et al. AMERICAN JOURNAL OF PATHOLOGY
- Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells
- (2009) Paul T. Brinkkoetter et al. JOURNAL OF CLINICAL INVESTIGATION
- Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death
- (2009) Bo Tian et al. NATURE CELL BIOLOGY
- The atypical kinase Cdk5 is activated by insulin, regulates the association between GLUT4 and E-Syt1, and modulates glucose transport in 3T3-L1 adipocytes
- (2009) V. Lalioti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Unusual Member of the Cdk Family: Cdk5
- (2008) Fatema A. Dhariwala et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor
- (2008) Nicholas C Turner et al. EMBO JOURNAL
- Cyclin-Dependent Kinase 5 Supports Neuronal Survival through Phosphorylation of Bcl-2
- (2008) Z. H. Cheung et al. JOURNAL OF NEUROSCIENCE
- Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion
- (2008) R. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started